A lot has changed since the passage of the Harrison Narcotics Act of 1914, the first comprehensive law in the US to regulate whole classes of drugs. Almost 110 years later distributors have moved online, prices have increased, and needs for prescription medications have continued to rise. With these and other changes, it’s imperative to revisit the processes and procedures by which patients acquire drug treatments. How could prices decrease? What are the opportunities for greater efficiency? Hear experts’ views as they discuss the future of prescription medicine in the US—how to streamline the acquisition process and make it more accessible for all who need pharmaceutical treatments. 

Moderator

Alex Knapp

Senior Editor, Healthcare and Science, Forbes

Speakers

Christine Baeder

Senior Vice President, Chief Operating Officer for US Generics and Global Biosimilars, Teva Pharmaceutical Industries Ltd.

Vin Gupta

Chief Medical Officer, Amazon Pharmacy

Jon Mahrt

Chief Operating Officer, Optum